Exchange: NASDAQ·Updated 07:30 PM EDT
KOD logo

KOD Kodiak Sciences Inc

$32.71
$0.14
(0.43%)
Today
Closed $32.71
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$2.06B
Vol1.61M

About KOD

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
45

Neutral Sentiment

How do you feel about KOD?

Advertisement|Remove ads.